These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 23144710)

  • 1. Quantitative proteomic analysis of Niemann-Pick disease, type C1 cerebellum identifies protein biomarkers and provides pathological insight.
    Cologna SM; Jiang XS; Backlund PS; Cluzeau CV; Dail MK; Yanjanin NM; Siebel S; Toth CL; Jun HS; Wassif CA; Yergey AL; Porter FD
    PLoS One; 2012; 7(10):e47845. PubMed ID: 23144710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human and mouse neuroinflammation markers in Niemann-Pick disease, type C1.
    Cologna SM; Cluzeau CV; Yanjanin NM; Blank PS; Dail MK; Siebel S; Toth CL; Wassif CA; Lieberman AP; Porter FD
    J Inherit Metab Dis; 2014 Jan; 37(1):83-92. PubMed ID: 23653225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered levels and distribution of amyloid precursor protein and its processing enzymes in Niemann-Pick type C1-deficient mouse brains.
    Kodam A; Maulik M; Peake K; Amritraj A; Vetrivel KS; Thinakaran G; Vance JE; Kar S
    Glia; 2010 Aug; 58(11):1267-81. PubMed ID: 20607864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A differential proteomics study of cerebrospinal fluid from individuals with Niemann-Pick disease, Type C1.
    Li W; Pergande MR; Crutchfield CA; Searle BC; Backlund PS; Picache JA; Burkert K; Yanjanin-Farhat NM; Blank PS; Toth CL; Wassif CA; Porter FD; Cologna SM
    Proteomics; 2023 Jun; 23(11):e2200378. PubMed ID: 36638187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single Cell Transcriptome Analysis of Niemann-Pick Disease, Type C1 Cerebella.
    Cougnoux A; Yerger JC; Fellmeth M; Serra-Vinardell J; Martin K; Navid F; Iben J; Wassif CA; Cawley NX; Porter FD
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32731618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered transition metal homeostasis in Niemann-Pick disease, type C1.
    Hung YH; Faux NG; Killilea DW; Yanjanin N; Firnkes S; Volitakis I; Ganio G; Walterfang M; Hastings C; Porter FD; Ory DS; Bush AI
    Metallomics; 2014 Mar; 6(3):542-53. PubMed ID: 24343124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal gene expression in cerebellum of Npc1-/- mice during postnatal development.
    Liao G; Wen Z; Irizarry K; Huang Y; Mitsouras K; Darmani M; Leon T; Shi L; Bi X
    Brain Res; 2010 Apr; 1325():128-40. PubMed ID: 20153740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative, Label-Free Proteomics in the Symptomatic Niemann-Pick, Type C1 Mouse Model Using Standard Flow Liquid Chromatography and Thermal Focusing Electrospray Ionization.
    Pergande MR; Nguyen TTA; Haney-Ball C; Davidson CD; Cologna SM
    Proteomics; 2019 May; 19(9):e1800432. PubMed ID: 30888112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann-Pick disease type C1 mice.
    Williams IM; Wallom KL; Smith DA; Al Eisa N; Smith C; Platt FM
    Neurobiol Dis; 2014 Jul; 67():9-17. PubMed ID: 24631719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative Proteomics of Human Fibroblasts with I1061T Mutation in Niemann-Pick C1 (NPC1) Protein Provides Insights into the Disease Pathogenesis.
    Rauniyar N; Subramanian K; Lavallée-Adam M; Martínez-Bartolomé S; Balch WE; Yates JR
    Mol Cell Proteomics; 2015 Jul; 14(7):1734-49. PubMed ID: 25873482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry imaging and LC/MS reveal decreased cerebellar phosphoinositides in Niemann-Pick type C1-null mice.
    Pathmasiri KC; Pergande MR; Tobias F; Rebiai R; Rosenhouse-Dantsker A; Bongarzone ER; Cologna SM
    J Lipid Res; 2020 Jul; 61(7):1004-1013. PubMed ID: 32371566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Niemann-Pick C1 mouse models, glial-only expression of the normal gene extends survival much further than do changes in genetic background or treatment with hydroxypropyl-beta-cyclodextrin.
    Marshall CA; Watkins-Chow DE; Palladino G; Deutsch G; Chandran K; Pavan WJ; Erickson RP
    Gene; 2018 Feb; 643():117-123. PubMed ID: 29223359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased activity and altered subcellular distribution of lysosomal enzymes determine neuronal vulnerability in Niemann-Pick type C1-deficient mice.
    Amritraj A; Peake K; Kodam A; Salio C; Merighi A; Vance JE; Kar S
    Am J Pathol; 2009 Dec; 175(6):2540-56. PubMed ID: 19893049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Presymptomatic Alterations in Amino Acid Metabolism and DNA Methylation in the Cerebellum of a Murine Model of Niemann-Pick Type C Disease.
    Kennedy BE; Hundert AS; Goguen D; Weaver IC; Karten B
    Am J Pathol; 2016 Jun; 186(6):1582-97. PubMed ID: 27083515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in gene expression in mutant amyloid precursor protein transgenic mice lacking Niemann-Pick type C1 protein.
    Maulik M; Thinakaran G; Kar S
    PLoS One; 2013; 8(1):e54605. PubMed ID: 23382922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Proteomics Reveals miR-155 as a Novel Indicator of Liver and Spleen Pathology in the Symptomatic Niemann-Pick Disease, Type C1 Mouse Model.
    Pergande MR; Cougnoux A; Rathnayake RAC; Porter FD; Cologna SM
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30870990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Potential Role of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) in Niemann-Pick Disease, Type C1.
    Cawley NX; Lyons AT; Abebe D; Wassif CA; Porter FD
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental delay in motor skill acquisition in Niemann-Pick C1 mice reveals abnormal cerebellar morphogenesis.
    Caporali P; Bruno F; Palladino G; Dragotto J; Petrosini L; Mangia F; Erickson RP; Canterini S; Fiorenza MT
    Acta Neuropathol Commun; 2016 Sep; 4(1):94. PubMed ID: 27586038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative Analysis of the Proteome Response to the Histone Deacetylase Inhibitor (HDACi) Vorinostat in Niemann-Pick Type C1 disease.
    Subramanian K; Rauniyar N; Lavalleé-Adam M; Yates JR; Balch WE
    Mol Cell Proteomics; 2017 Nov; 16(11):1938-1957. PubMed ID: 28860124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microglia activation in Niemann-Pick disease, type C1 is amendable to therapeutic intervention.
    Cougnoux A; Drummond RA; Collar AL; Iben JR; Salman A; Westgarth H; Wassif CA; Cawley NX; Farhat NY; Ozato K; Lionakis MS; Porter FD
    Hum Mol Genet; 2018 Jun; 27(12):2076-2089. PubMed ID: 29617956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.